What question did this study set out to answer?

To analyze healthcare resource utilization and costs associated with chronic kidney disease across KDIGO categories in Spain.

February 10, 2026Open Access

View Full Paper

Healthcare resource utilization and costs of chronic kidney disease in Spain across KDIGO categories: Insights from real-world evidence

RSRafael SantamariaInstituto Maimónides de Investigación Biomédica de Córdoba CECarlos EscobarHospital Universitario La Paz UAUnai ArandaAstraZeneca (France)

Key Points

To analyze healthcare resource utilization and costs associated with chronic kidney disease across KDIGO categories in Spain.
Real-world evidence analysis of healthcare data
Assessment of resource utilization based on KDIGO categories
Evaluation of costs associated with worsening renal function and albuminuria levels
Higher healthcare costs linked to worse renal function and increased albuminuria
Economic burden underscored the need for comprehensive management strategies
Emphasis on preventive policies and kidney protective drug use

Abstract

In real-world, CKD may be associated with high healthcare resource utilization and costs that increase as renal function worsens or albuminuria levels increase. Reducing economic burden through primordial and primary prevention policies, and comprehensive management with kidney protective drugs should be a priority.

Ask AI

Helpful

Bookmark

View Full Paper

Ask AI

Helpful

Bookmark

View Full Paper

Healthcare resource utilization and costs of chronic kidney disease in Spain across KDIGO categories: Insights from real-world evidence

Key Points

Abstract

Cite This Study